Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.

Oncotarget · 2016 · PMC5308751 · PMID 27566586

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significancep =0.053so close (0.05 < p ≤ 0.1)

Postoperative pathological conditions Among patients who underwent standard radical lung cancer resection, the complete resection ratio tended to be higher in the test group at 93.8% (15/16) than in the control group at 62.5% (5/8), although this difference did not reach statistical significance ( p =0.053).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.